Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Board

I've been thinking about that also. Patents run out in 2015, can't litigate past 2018. Just how many people are going to invest in this company for such a short period of time. Doesn't seem that there would be a line of people buying your shares, stay in too long for the dividends then how you going to unload all your shares?

Share
New Message
Please login to post a reply